Pharmacological characterization of the opioid inactive isomers (+)-naltrexone and (+)-naloxone as antagonists of toll-like receptor 4
about
Structure-Activity Relationships of (+)-Naltrexone-Inspired Toll-like Receptor 4 (TLR4) Antagonists.Comparison of (+)- and (-)-Naloxone on the Acute Psychomotor-Stimulating Effects of Heroin, 6-Acetylmorphine, and Morphine in Mice.Recent progress in the development of Toll-like receptor (TLR) antagonists.Glial and Neuroimmune Mechanisms as Critical Modulators of Drug Use and Abuse.Inflammatory responses to alcohol in the CNS: nuclear receptors as potential therapeutics for alcohol-induced neuropathologiesThe role of neuroimmune signaling in alcoholism.Naltrexone Inhibits IL-6 and TNFα Production in Human Immune Cell Subsets following Stimulation with Ligands for Intracellular Toll-Like Receptors.Lack of Specific Involvement of (+)-Naloxone and (+)-Naltrexone on the Reinforcing and Neurochemical Effects of Cocaine and Opioids.Genetic and Pharmacologic Manipulation of TLR4 Has Minimal Impact on Ethanol Consumption in Rodents.Toll-like receptors and their role in persistent pain.The activation of μ-opioid receptor potentiates LPS-induced NF-kB promoting an inflammatory phenotype in microglia.Nalmefene Prevents Alcohol-Induced Neuroinflammation and Alcohol Drinking Preference in Adolescent Female Mice: Role of TLR4.Preparative Separation and Purification of Four Glycosides from Gentianae radix by High-Speed Counter-Current Chromatography and Comparison of Their Anti-NO Production Effects.Innate Immune Signaling and Alcohol Use Disorders.Low dose Naltrexone for induction of remission in inflammatory bowel disease patients.Neuroinflammation and Central Sensitization in Chronic and Widespread Pain.Post-stroke Intranasal (+)-Naloxone Delivery Reduces Microglial Activation and Improves Behavioral Recovery from Ischemic Injury.Differential effect of morphine on gastrointestinal transit, colonic contractions and nerve-evoked relaxations in Toll-Like Receptor deficient mice.
P2860
Q36253520-72BD5011-816C-4003-9435-ADF9D3851863Q37122017-ACD663FC-3944-4193-9FC4-98A92BE9B75AQ38823065-076149E7-6546-4F80-BE59-FDECEB7AAD95Q38893386-0EA22399-B038-4588-93AF-33A4E3F6EC31Q38909821-687CF583-BCC8-4FA5-B4E3-C72767F2A18EQ39118808-C412A690-8118-468F-8E9C-1262BF00DD85Q40119691-0623D4D3-4806-4CB7-A0A8-BCCA8D656FA4Q41654778-14F60419-F169-4FDC-BB24-B2553B5A83CBQ42323311-B42A658C-BB44-46B0-8607-BE97FFB47E39Q43075865-4C786766-C9FB-47AF-B52D-FC7A6A645316Q44338722-6A8875DE-1DB2-4876-9EAE-E55773F4E803Q47767037-32E75C58-FA72-411C-A72E-8656AD095103Q47792466-01542B31-9AD0-4BAE-8669-8EFD4E4653F2Q52316042-72C7B535-337B-474F-A7AB-4DFD38D0D89EQ52664057-81441EC6-0FF0-4D8B-AB0B-DAED6945923BQ52692785-AFD7F6C0-A713-4519-976F-359B46FB159BQ54941237-633B9CA5-3C9A-45DF-8952-C516DB9E8177Q54965753-6C858681-EA30-4B6B-AF24-5FF1E1B11F7A
P2860
Pharmacological characterization of the opioid inactive isomers (+)-naltrexone and (+)-naloxone as antagonists of toll-like receptor 4
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Pharmacological characterizati ...... onists of toll-like receptor 4
@ast
Pharmacological characterizati ...... onists of toll-like receptor 4
@en
type
label
Pharmacological characterizati ...... onists of toll-like receptor 4
@ast
Pharmacological characterizati ...... onists of toll-like receptor 4
@en
prefLabel
Pharmacological characterizati ...... onists of toll-like receptor 4
@ast
Pharmacological characterizati ...... onists of toll-like receptor 4
@en
P2093
P2860
P356
P1476
Pharmacological characterizati ...... onists of toll-like receptor 4
@en
P2093
P2860
P304
P356
10.1111/BPH.13394
P407
P577
2016-02-04T00:00:00Z